| |
| |
|
| Insider
Information: |
Olson Eric R |
| Relationship: |
Chief Scientific Officer |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
6,661 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$33,372 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
6,661 |
|
|
| Total
Value |
$33,372 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Syros Pharmaceuticals, Inc. |
SYRS |
Chief Scientific Officer |
2023-07-17 |
6,661 |
2017-07-25 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SYRS |
Syros Pharmaceuticals, In... |
Chief Scientific Officer |
• – – |
2023-07-17 |
4 |
AS |
$3.50 |
$2,412 |
D/D |
(689) |
6,661 |
0 |
% |
|
| SYRS |
Syros Pharmaceuticals, In... |
Chief Scientific Officer |
• – – |
2022-04-01 |
4 |
D |
$1.12 |
$30,538 |
D/D |
(27,266) |
59,734 |
0 |
- |
|
| SYRS |
Syros Pharmaceuticals, In... |
Chief Scientific Officer |
• – – |
2022-01-05 |
4 |
AS |
$3.47 |
$7,655 |
D/D |
(2,208) |
0 |
0 |
% |
|
| SYRS |
Syros Pharmaceuticals, In... |
Chief Scientific Officer |
• – – |
2021-07-01 |
4 |
AS |
$5.55 |
$6,460 |
D/D |
(1,164) |
0 |
0 |
% |
|
| SYRS |
Syros Pharmaceuticals, In... |
Chief Scientific Officer |
• – – |
2021-03-15 |
4 |
AS |
$9.47 |
$34,372 |
D/D |
(3,628) |
0 |
0 |
% |
|
| SYRS |
Syros Pharmaceuticals, In... |
Chief Scientific Officer |
• – – |
2021-03-15 |
4 |
OE |
$1.01 |
$3,664 |
D/D |
3,628 |
3,628 |
0 |
- |
|
| SYRS |
Syros Pharmaceuticals, In... |
Chief Scientific Officer |
• – – |
2020-08-18 |
4 |
AS |
$13.00 |
$140,231 |
D/D |
(10,787) |
0 |
0 |
% |
|
| SYRS |
Syros Pharmaceuticals, In... |
Chief Scientific Officer |
• – – |
2020-08-18 |
4 |
OE |
$1.01 |
$10,895 |
D/D |
10,787 |
10,787 |
0 |
- |
|
| SYRS |
Syros Pharmaceuticals, In... |
Chief Scientific Officer |
• – – |
2020-08-17 |
4 |
AS |
$13.00 |
$64,519 |
D/D |
(4,963) |
0 |
0 |
% |
|
| SYRS |
Syros Pharmaceuticals, In... |
Chief Scientific Officer |
• – – |
2020-08-17 |
4 |
OE |
$1.01 |
$5,013 |
D/D |
4,963 |
4,963 |
0 |
- |
|
| SYRS |
Syros Pharmaceuticals, In... |
Chief Scientific Officer |
• – – |
2020-07-07 |
4 |
AS |
$11.72 |
$20,538 |
D/D |
(1,753) |
0 |
0 |
% |
|
| SYRS |
Syros Pharmaceuticals, In... |
Chief Scientific Officer |
• – – |
2020-02-18 |
4 |
AS |
$7.38 |
$10,674 |
D/D |
(1,446) |
0 |
0 |
% |
|
| SYRS |
Syros Pharmaceuticals, In... |
Chief Scientific Officer |
• – – |
2019-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
87,000 |
87,000 |
0 |
- |
|
| SYRS |
Syros Pharmaceuticals, In... |
Chief Scientific Officer |
• – – |
2017-07-25 |
4 |
AS |
$21.85 |
$273,125 |
D/D |
(12,500) |
0 |
0 |
- |
|
| SYRS |
Syros Pharmaceuticals, In... |
Chief Scientific Officer |
• – – |
2017-07-25 |
4 |
OE |
$1.01 |
$12,625 |
D/D |
12,500 |
12,500 |
0 |
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
